# Onno Stolpe

> Onno Stolpe is a seed investor at Forbion Capital Partners backing Medical and Health Care. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Forbion Capital Partners](https://shizune.co/investors/profile/forbion-capital-partners)
- Location: The Hague, The Netherlands
- Total investments: 1
- Last investment: Apr 2022
- Lead investor: 0%
- Last updated: Aug 2026

Onno Stolpe is a seed investor at Forbion Capital Partners in The Hague focused on Medical and Health Care. Onno Van de Stolpe is based out of Naarden, Noord-Holland, and is the Venture Partner of Forbion Capital Partners. Onno previously worked at Galapagos as a CEO. Onno Van de Stolpe attended Wageningen University and Research.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 100% |
| Health Care | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Xinvento | Xinvento provides a credible alternative treatment for congenital hyperinsulinism. |  | Seed | Apr 21, 2022 |  |

1 of 1 investments shown.

## About Forbion Capital Partners

VC Fund · Naarden, The Netherlands

Forbion Capital Partners is a Netherlands-based venture capital firm focused on investing in life sciences companies in drug development as well as MedTech companies addressing high medical needs. Forbion's investment team of nine investment professionals has built an impressive performance track record since the late nineties with successfulinvestments in Rhein Biotech, Crucell, Neutec, Glycart, Borean, Impella, Alantos, Acorda, Fovea and PanGenetics. Current assets under management exceed €400m ($500m), split between three active funds. Finally, Forbion co-manages BioGeneration Ventures, an early stage fund focused on academic spin-outs and seed investments in the Netherlands.

5 contacts available at Forbion Capital Partners.

| Name | Title | Profile |
| --- | --- | --- |
| Joy Faucher | General Partner | https://shizune.co/investors/profile/joy-faucher-c13e |
| Marco Boorsma | General Partner | https://shizune.co/investors/profile/marco-boorsma |
| Nanna Lüneborg | General Partner | https://shizune.co/investors/profile/nanna-lneborg |
| Onno Stolpe | Venture Partner | https://shizune.co/investors/profile/onno-van-de-stolpe |
| Sander Slootweg | Managing Partner and co-founder | https://shizune.co/investors/profile/sander-slootweg |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Onno Stolpe invest in?

Onno Stolpe invests primarily in Medical and Health Care startups, most often at Seed stage. Most of the 1 investments tracked by Shizune back companies in The Netherlands. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Onno Stolpe last invest?

The most recent investment recorded for Onno Stolpe closed in Apr 2022. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co